BridgeMD
Compares treatment options for Esophagus Cancer
Official title Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
ClinicalTrials.gov ID: NCT02972372
What this study is testing
- What it's testing
- The aim of this study is to compare outcomes in Chinese patients with locally advanced resectable esophageal squamous cell cancer who have received either surgery or definitive chemoradiation (CRT) by the randomized, open-label, multicenter trial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Chinese
- esophageal squamous cell cancer
- mid or lower esophageal cancer
- tumor is resectable disease
- clinical stage: cT1bN+Mo, or cT2-4aN0-2M0
You likely can't join if
- who had distant metastasis to solid visceral organs or local invasion into trachea, descending aorta, or recurrent laryngeal nerve.
- who had a serious premorbid condition or a poor physical status that compromised a thoracotomy.
The study team makes the final eligibility decision.
Where it's taking place
- Anyang, Henan, China
- Luoyang, Henan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Anyang, Henan, China; Luoyang, Henan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.